Skip to main content
. Author manuscript; available in PMC: 2020 Oct 11.
Published in final edited form as: ACS Infect Dis. 2019 Aug 14;5(10):1738–1753. doi: 10.1021/acsinfecdis.9b00168

Table 2.

EC50 and IC50 values for the six selected compounds in various yeast, parasite, red blood cell, and physicochemical assays.a

Compounds
GSK-1 GSK-2 GSK-3 GSK-4 GSK-5 GSK-6
Yeast HTS Growth Assay-GSK (μM) 3.16 0.25 2.51 3.98 63.1 10
Yeast Kill Assay-GSK (μM) 0.63 <0.08 0.63 1.26 6.31 1.26
Yeast Kill Assay-Akabas lab (μM) 0.54 ± 0.20 0.11 ± 0.04 0.46 ± 0.30 0.43 ± 0.30 4.0 ± 1.3 1.2 ± 1.1
PfENT1 [3H]Ado uptake (μM) 0.12 ± 0.08 0.03 ± 0.03 0.03 ± 0.01 0.02 ± 0.01 2.59 ± 2.36 3.98 ± 1.35
PvENT1 [3H]Ado uptake (μM)b 0.14 ± 0.07 0.04 ± 0.03 0.04 ± 0.01 0.02 ± 0.04 2.71 ± 0.25 NEd
PbENT1 [3H]Ado uptake (μM)c 0.13 ± 0.05 0.05 ± 0.03 0.07 ± 0.04 0.01 ± 0.01 3.09 ± 2.70 NEd
3D7 (μM) 0.78 ± 0.2 2.25 ± 0.4 2.38 ± 0.5 6.20 ± 1.9 8.72 ± 1.6 10.3 ± 4.7
PfENT1-KO (μM) 17 ± 4.8 2.66 Low activity/NEe 29.4 ± 0.5 10.8 NEe
Dd2 (μM) 0.11 ± 0.009 1.89 ± 0.2 0.59 ± 0.05 1.90 ± 0.4 10.6 ± 2.1 3.3 ± 1.7
HB3 (μM) 0.34 ± 0.1 3.55 ± 0.7 2.21 ± 0.6 6.16 ± 2.5 9.09 ± 4.5 19.7 ± 4.1
7G8 (μM) 0.48 ± 0.2 4.52 ± 0.1 6.08 ± 1.3 8.44 ± 2.4 16.1 ± 5.5 19.0 ± 3.5
Cam3.II Artemisinin resistant (μM) 0.16 ± 0.09 1.37 ± 0.2 0.79 ± 0.2 3.02 ± 1.6 8.37 ± 1.4 6.07 ± 1.0
hENT1 [3H]adenosine uptake into RBC (μM) 0.99 ± 0.81 24.5 ± 24.8 72.4 ± 19.3 51.0 ± 27.7 Low activity/NEd NEd
hFNT [3H]hypoxanthine uptake into RBC (μM) 0.38 ± 0.1 NEd 9.93 ± 4.1 NEd 3.54 ± 1.5 NEd
HepG2 cell cytotoxicity (μM)f >100 >100 >100 >100 >100 >100
Molecular weight 475 402 363 341 254 338
Solubility (μg/mL) 10.5 2.5 112 156 16 >133
ChromLogDpH7.4g 4.8 6.8 4 4.5 3.7 1.2
PFIh 8.8 9.6 6 6.5 5.7 4.2
HSA Column bindingi 94% 97% 84% 92% 90% 48%
a

Values are mean ± SD. N ≥ 3 for all experiments except for the “5-FUrd growth assay-GSK” and the “Ado dependent growth-GSK columns”, where N=2, and for the PfENT1-KO experiments with compounds GSK-2 and GSK-5, where N=1.

b

PvENT1, yeast expressing the P. vivax ENT1 homologue

c

PbENT1, yeast expressing the mouse malaria model P. berghei ENT1 homologue

d

NE, no effect at the maximum concentration tested, 100 μM. Low activity/NE, indicates that at the highest concentration tested there seemed to be an effect, but it was not sufficient to calculate an IC50 value.

e

NE, no effect at the maximum concentration tested, 74.2 μM. Low activity/NE, indicates that at the highest concentration tested there seemed to be an effect, but it was not sufficient to calculate an IC50 value.

f

For the HepG2 cell cytotoxicity data, and >100 indicates no cytotoxicity up to 100 μM.

g

ChromLogDpH7.4, chromatographic log of the distribution constant at pH 7.4.59, 60, 63

h

PFI, Property Forecast Index.31, 63

i

HSA, human serum albumin.61